129 related articles for article (PubMed ID: 20159176)
1. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
Massaro M; Di Carlo C; Gargano V; Formisano C; Bifulco G; Nappi C
Contraception; 2010 Mar; 81(3):209-14. PubMed ID: 20159176
[TBL] [Abstract][Full Text] [Related]
2. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
[TBL] [Abstract][Full Text] [Related]
3. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
Nappi C; Di Spiezio Sardo A; Greco E; Tommaselli GA; Giordano E; Guida M
Obstet Gynecol; 2005 Jan; 105(1):53-60. PubMed ID: 15625142
[TBL] [Abstract][Full Text] [Related]
4. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
Massai R; Mäkäräinen L; Kuukankorpi A; Klipping C; Duijkers I; Dieben T
Hum Reprod; 2005 Oct; 20(10):2764-8. PubMed ID: 15980008
[TBL] [Abstract][Full Text] [Related]
5. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213
[TBL] [Abstract][Full Text] [Related]
6. Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study.
Harel Z; Riggs S; Vaz R; Flanagan P; Harel D; Machan JT
J Pediatr Adolesc Gynecol; 2010 Feb; 23(1):23-31. PubMed ID: 19647454
[TBL] [Abstract][Full Text] [Related]
7. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Nappi C; Di Spiezio Sardo A; Acunzo G; Bifulco G; Tommaselli GA; Guida M; Di Carlo C
Contraception; 2003 May; 67(5):355-9. PubMed ID: 12742557
[TBL] [Abstract][Full Text] [Related]
8. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis.
Vercellini P; Barbara G; Somigliana E; Bianchi S; Abbiati A; Fedele L
Fertil Steril; 2010 May; 93(7):2150-61. PubMed ID: 19328469
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary study.
Di Carlo C; Gargano V; Sparice S; Tommaselli GA; Bifulco G; Schettino D; Nappi C
Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):388-93. PubMed ID: 23859010
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive.
Elkind-Hirsch KE; Darensbourg C; Ogden B; Ogden LF; Hindelang P
Contraception; 2007 Nov; 76(5):348-56. PubMed ID: 17963858
[TBL] [Abstract][Full Text] [Related]
11. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
13. Extended regimens of the vaginal contraceptive ring: cycle control.
Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF
Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716
[TBL] [Abstract][Full Text] [Related]
14. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
Paoletti AM; Orrù M; Lello S; Floris S; Ranuzzi F; Etzi R; Zedda P; Guerriero S; Fratta S; Sorge R; Mallarini G; Melis GB
Contraception; 2004 Oct; 70(4):293-8. PubMed ID: 15451333
[TBL] [Abstract][Full Text] [Related]
15. Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
O'Connell KJ; Osborne LM; Westhoff C
Contraception; 2005 Nov; 72(5):323-7. PubMed ID: 16246655
[TBL] [Abstract][Full Text] [Related]
16. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
Barreiros FA; Guazzelli CA; Barbosa R; Torloni MR; Barbieri M; Araujo FF
Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormonal contraception on bone mineral density after 24 months of use.
Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive.
van den Heuvel MW; van Bragt AJ; Alnabawy AK; Kaptein MC
Contraception; 2005 Sep; 72(3):168-74. PubMed ID: 16102549
[TBL] [Abstract][Full Text] [Related]
19. Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls.
Lattakova M; Borovsky M; Payer J; Killinger Z
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):207-14. PubMed ID: 19565418
[TBL] [Abstract][Full Text] [Related]
20. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
